Wernicke Encephalopathy Identified During FOLFOX Therapy for Rectal Cancer
A 55-year-old woman developed Wernicke encephalopathy (WE) during neoadjuvant FOLFOX therapy for rectal adenocarcinoma, highlighting diagnostic challenges and the role of thiamine deficiency in oncology patients, … Read more